FDA-approved medicines exist for specific indications

Gonadorelin

Native GnRH-I decapeptide — diagnostic / pulsatile HH reproductive-endocrine object; ≠ agonists or kisspeptin.

Editorial review:

What evidence says

Evidence snapshot

This drawer marks papers. It is not a plan, a dose, or a source. A paper is a bounded report. It is not a protocol. Grades name the object. They are not a safety rating.

Identity lock. Gonadorelin is synthetic mammalian GnRH-I (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) — the native decapeptide sequence used as a pharmaceutical identity (Factrel / Lutrelef-class diagnostic and pulsatile-therapy framing in various jurisdictions). PubChem CID 638793; formula C55H75N17O13 / MW 1182.3; CAS 33515-09-2. Acetate salt CID 11980076 exists as a related salt record. ≠ GnRH agonists (leuprolide, triptorelin, etc.), ≠ GnRH antagonists, ≠ kisspeptin, ≠ gonadotropins (hCG/hMG/FSH/LH). Labeled objects historically include diagnostic GnRH stimulation testing and, in specialized centers, pulsatile GnRH for selected hypogonadotropic hypogonadism / infertility pathways. This drawer marks papers. It is not use advice.

Bottom line

Gonadorelin is the native-sequence GnRH drug object used in endocrine diagnosis and in specialized pulsatile replacement paradigms for congenital/functional hypogonadotropic hypogonadism. Consensus CHH reviews (Boehm; Young) frame when pulsatile GnRH vs exogenous gonadotropins are considered — those are reproductive-medicine contexts, not physique or “GnRH peptide” lifestyle claims. Agonist/antagonist IVF drugs are different drawers conceptually.

Papers

Identity / receptor / pathophysiology

PMID 26715597 — Maggi 2016

Tested: review of GnRH and GnRH receptors in pathophysiology of the human female reproductive system.

Does not show: a physique indication, or that agonists equal native gonadorelin.

PMID 29123501 — Flanagan 2017

Tested: review of GnRH receptor structure and GnRH binding.

Does not show: clinical outcome data by itself.

PMID 33238870 — Bettocchi 2021

Tested: review of GnRH in treatment of hypogonadotropic hypogonadism.

Does not show: interchangeability with hCG/hMG regimens without clinical context.

Congenital / hypogonadotropic hypogonadism — clinical management context

PMID 26194704 — Boehm 2015

Tested: European consensus statement on congenital hypogonadotropic hypogonadism — pathogenesis, diagnosis, treatment (includes pulsatile GnRH framing among options).

Does not show: a consumer peptide license or sports use.

PMID 30698671 — Young 2019

Tested: Endocrine Reviews clinical management of congenital hypogonadotropic hypogonadism (diagnostic and therapeutic pathways including gonadotropin vs pulsatile GnRH contexts).

Does not show: off-label physique use support.

PMID 9922906 — Hayes 1998

Tested: clinical review of hypogonadotropic hypogonadism (classic endocrine framing including GnRH testing/therapy concepts).

Does not show: modern product-specific labeling for every jurisdiction.

PMID 12536356 — Silveira 2002

Tested: review of hypogonadotropic hypogonadism genetics/clinical spectrum.

Does not show: a new pivotal gonadorelin RCT by itself.

PMID 37958948 — Fanis 2023

Tested: GnRH receptor biology in hypogonadotropic hypogonadism context.

Does not show: performance-enhancement evidence.

Pulsatile / puberty-induction adjacent reviews

PMID 18796540 — Delemarre 2008

Tested: review of inducing puberty (includes GnRH-axis replacement concepts).

Does not show: adult physique applications.

PMID 38683021 — Abacı 2024

Tested: current perspective on delayed puberty and management (axis-hormone options in pediatric endocrine context).

Does not show: that pediatric endocrine protocols transfer to unlabeled adult “GnRH peptide” use.

What is not established

That gonadorelin equals long-acting GnRH agonists or antagonists. Consumer or athletic use outside labeled/specialty reproductive-endocrine pathways. Product identity for unregulated “GnRH” vials vs pharmaceutical gonadorelin. This drawer does not provide use advice, schedules, or sourcing.

Selected sources

26715597 29123501 33238870 26194704 30698671 9922906 12536356 37958948 18796540 38683021

What people discuss

Reported experiences

Reported topics are not established benefits.

Watch for

Risks and unknowns

Context matters. Approval of one medicine, formulation, or use does not establish approval of products sold online or other uses. This page is educational and does not provide dosing or treatment advice.

Member discussion

Compare experiences with care.

Before posting: Describe firsthand observations and uncertainty. Do not prescribe, arrange transactions, or post private health information.

◎Verified members

Join the discussion

Verified members can contribute to compound conversations.

No approved member reports yet. Thoughtful first contributions are welcome.